Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
Background: Flutamide has been rarely used for the treatment of female pattern hair loss (FPHL ... Results: Both groups showed a marked decrease in alopecia scores after 12 months of flutamide ...
Following after are etrasimod studies in Crohn's disease, eosinophilic oesophagitis, alopecia areata and atopic dermatitis, which if positive could dramatically increase the drug's potential.